title: Editorial comment on: Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
authors.forename: Giacomo
authors.initials: G
authors.lastname: Novara
mesh_terms: D015415:Biomarkers / Q000652:urine; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D003430:Cross-Sectional Studies; D018450:Disease Progression; D006801:Humans; D020932:Nerve Growth Factor / Q000652:urine*; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000652:urine*
chemical_list: D015415:Biomarkers; D009465:Neuromuscular Agents; D020932:Nerve Growth Factor; D019274:Botulinum Toxins, Type A